Orgenesis is a global biotech company working to unlock the full potential of cell and gene therapies (CGTs) in an affordable and accessible format at the point of care. The Orgenesis POCare Platform is comprised of three enabling components: a pipeline of licensed POCare Therapeutics that are processed and produced in closed, automated POCare Technology systems across a collaborative POCare Network. Orgenesis also offers cost-effective scalable solutions to GMP supply constraints. The POCare™ platform is a unique globally harmonized and decentralized CGT manufacturing infrastructure and offers cost-effective manufacturing capacities with ease for scalability and reproducibility.”